Decrease Obstructive Sleep Apnea (OSA) Sympathetic Tone : Impact of APAP vs CPAP
APAP-CPAP
Decrease in Sympathetic Tone in OSA Patients: Is CPAP More Effective Than APAP ?
1 other identifier
interventional
57
1 country
1
Brief Summary
The present study aims to compare muscle sympathetic neural activity by microneurography after one month treatment of fixed versus auto-adjusting CPAP treatment and its impact on arterial blood pressure
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 17, 2018
CompletedFirst Posted
Study publicly available on registry
February 9, 2018
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 17, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2022
CompletedMay 16, 2024
July 1, 2022
4.7 years
January 17, 2018
May 13, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Sympathetic tone (MSNA)
Change from Baseline Sympathetic tone at 1 months
Change from baseline after one month of intervention
Secondary Outcomes (11)
24 hours Systolic Blood pressure (AMBP)
Change from baseline after one month of intervention
Systolic Blood pressure (office)
Change from baseline after one month of intervention
Diastolic Blood pressure (office) change after 1 month
Change from baseline after one month of intervention
Mean Blood pressure (office)
Change from baseline after one month of intervention
Catecholamines (epinephrine)
Change from baseline after one month of intervention
- +6 more secondary outcomes
Study Arms (2)
Fixed CPAP
EXPERIMENTALCPAP always deliver air with the same pressure
Auto-adjusting CPAP
ACTIVE COMPARATORAuto-CPAP changes the pressure delivered depending on events detected at any time (apnea, hypopnea …) and applies the lowest pressure required to eliminate events.
Interventions
CPAP is a device that applies continous fixed positive pressure to the airways in order to keep them opened during sleep
Auto-adjusting CPAP is a device that applies auto-adjusting continous positive pressure to the airways in order to keep them opened during sleep
Eligibility Criteria
You may qualify if:
- patient with OSA (AHI ≥20 / h)
- patient with daytime sleepiness
- naive of any pressure treatment of OSA
- patient able to provide written informed consent
- not a vulnerable person or legally protected adult.
You may not qualify if:
- pregnancy
- Person deprived of liberty or subject to a legal protection measure.
- Patient with serious heart failure (According to investigator judgment)
- patient with central sleep apnea index above 20% of AHI
- Patient with a significant intercurrent pathology that can influence the results. (According to investigator judgment).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital, Grenoblelead
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.collaborator
- ResMedcollaborator
- Agir pour les maladies chroniquescollaborator
Study Sites (1)
CHU Grenoble Alpes
Grenoble, 38000, France
Related Publications (2)
Pepin JL, Tamisier R, Baguet JP, Lepaulle B, Arbib F, Arnol N, Timsit JF, Levy P. Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial. Thorax. 2016 Aug;71(8):726-33. doi: 10.1136/thoraxjnl-2015-207700. Epub 2016 Apr 18.
PMID: 27091542BACKGROUNDTreptow E, Pepin JL, Bailly S, Levy P, Bosc C, Destors M, Woehrle H, Tamisier R. Reduction in sympathetic tone in patients with obstructive sleep apnoea: is fixed CPAP more effective than APAP? A randomised, parallel trial protocol. BMJ Open. 2019 Apr 4;9(4):e024253. doi: 10.1136/bmjopen-2018-024253.
PMID: 30948567DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Renaud Tamisier, MD, PhD
University Grenoble Alps
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 17, 2018
First Posted
February 9, 2018
Study Start
March 1, 2018
Primary Completion
November 17, 2022
Study Completion
November 30, 2022
Last Updated
May 16, 2024
Record last verified: 2022-07
Data Sharing
- IPD Sharing
- Will not share